Cargando…
An aptamer agonist of the insulin receptor acts as a positive or negative allosteric modulator, depending on its concentration
Aptamers are widely used as binders that interact with targets with high affinity or as inhibitors of the function of target molecules. However, they have also been used to modulate target protein function, which they achieve by activating the target or stabilizing its conformation. Here, we report...
Autores principales: | Yunn, Na-Oh, Lee, Jimin, Lee, Hye Sun, Oh, Eun Ju, Park, Mangeun, Park, Seongeun, Jin, Seo Yeon, Shin, Euisu, Lee, Jo woon yi, Kim, Youndong, Bae, Sun Sik, Ryu, Sung Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076861/ https://www.ncbi.nlm.nih.gov/pubmed/35478209 http://dx.doi.org/10.1038/s12276-022-00760-w |
Ejemplares similares
-
A hotspot for enhancing insulin receptor activation revealed by a conformation-specific allosteric aptamer
por: Yunn, Na-Oh, et al.
Publicado: (2021) -
Functional selectivity of insulin receptor revealed by aptamer-trapped receptor structures
por: Kim, Junhong, et al.
Publicado: (2022) -
Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulation
por: Yunn, Na-Oh, et al.
Publicado: (2015) -
Targeted Therapy of Hepatocellular Carcinoma Using Gemcitabine-Incorporated GPC3 Aptamer
por: Park, Jun Young, et al.
Publicado: (2020) -
Periostin-binding DNA aptamer treatment attenuates renal fibrosis under diabetic conditions
por: Um, Jae Eun, et al.
Publicado: (2017)